AMO Gets FDA Approval For New OVD | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Wednesday, July 4, 2012

Ocular Surgery News

The U.S. Food and Drug Administration has granted approval to Abbott Medical Optics for Healon EndoCoat OVD, according to a press release.

The most likely diagnosis is:
1. congenital glaucoma
2. birth trauma
3. hypotony
4. enlarged corneal nerves
Check The Answer

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse
CIRRUS HD-OCT 5000 is configured with ... view product
SPECTRALIS Diagnostic Imaging Platform
A modular and upgradeable ophthalmic ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us